3 Extended Administration Pharmacokinetics in DIO Mice Neelakantan et al., Biochemical Pharmacology (2024) This study reported a 28-day once-daily administration protocol of 5-Amino-1MQ in diet-induced obese mice, characterizing plasma pharmacokinetics, tissue distribution, and effects on body composition, fatty liver pathology, and circulating biomarkers
They face a higher risk of B12 deficiency
While their effectiveness is well-documented, understanding their safety is paramount
As the main problem lies in the lack of endogenous insulin production, all T1DM subjects will have low portal insulin levels, even when treated with subcutaneous insulin, as this will only increase systemic insulin concentrations
IV chelation is safe when administered by a well-trained team with certificate training and exams provided by ACAM American College of Alternative Medicine
Parker NP, Ardeshirpour F, Schmechel SC, Lassig AAD